Mirae Asset Global ETFs Holdings

Mirae Asset Global ETFs Holdings’s BioCryst Pharmaceuticals BCRX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.25M	Buy	131,160 +11,593	+10%	+$90K	﹤0.01%	1413
2025 Q4	$929K	Buy	119,567 +3,366	+3%	+$24.3K	﹤0.01%	1562
2025 Q3	$881K	Sell	116,201 -13,303	-10%	-$111K	﹤0.01%	1558
2025 Q2	$1.17M	Sell	129,504 -5,810	-4%	-$54.1K	﹤0.01%	1376
2025 Q1	$1.02M	Buy	135,314 +8,517	+7%	+$68.7K	﹤0.01%	1488
2024 Q4	$954K	Sell	126,797 -929	-0.7%	-$7.05K	﹤0.01%	1571
2024 Q3	$971K	Buy	127,726 +14,199	+13%	+$108K	﹤0.01%	1555
2024 Q2	$700K	Buy	+113,527	New	+$626K	﹤0.01%	1650

Other funds holding BCRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return